Home › Funds › University of Wisconsin Foundation › PCVX

University of Wisconsin Foundation position in PCVX

VAXCYTE INC · Health Care

University of Wisconsin Foundation reported holding 239,749 shares of PCVX (VAXCYTE INC) in its Q3 2026 13F filing — a position valued at US$13.6M, representing 9.33% of its reported portfolio and ranking #6 among its reported holdings. University of Wisconsin Foundation has disclosed PCVX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)239.75K sh
Reported value held$13.64M
Portfolio Weight9.33%
First reportedQ4 2025
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How University of Wisconsin Foundation's PCVX position evolved

University of Wisconsin Foundation first disclosed a stake in PCVX in Q4 2025 at 247,000 shares (US$11.4M). The position peaked in Q2 2026 at 239,749 shares, worth US$13.9M. Across 4 filings, University of Wisconsin Foundation increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 239,749 shares valued at US$13.6M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 247.00K $11.40M New
Q1 2026 239.75K $13.93M Reduce
Q2 2026 239.75K $13.94M Hold
Q3 2026 239.75K $13.64M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PCVX and 13F data

PCVX (VAXCYTE INC) is a Health Care company. 33 other funds we track also report a position in PCVX — the largest reported positions include Jupiter Topco LLC (US$1.04B), Janus Henderson Group (US$960.2M), T. Rowe Price Investment Management, Inc. (US$709.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PCVX

All PCVX fund holders →

FAQ

How long has University of Wisconsin Foundation held PCVX?

University of Wisconsin Foundation has disclosed PCVX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is University of Wisconsin Foundation's current position in PCVX?

As of Q3 2026, University of Wisconsin Foundation holds 239.75K shares of PCVX (VAXCYTE INC), valued at $13.64M, representing 9.33% of its reported portfolio and ranking #6.

Has University of Wisconsin Foundation been buying or selling PCVX?

In the latest 13F filing (Q3 2026), University of Wisconsin Foundation held unchanged its position in PCVX. The position peaked in Q2 2026 at 239.75K shares.

Which other funds hold PCVX?

Other major institutional holders of PCVX include Jupiter Topco LLC, Janus Henderson Group, T. Rowe Price Investment Management, Inc., among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.